
McKesson Corporation – NYSE:MCK
McKesson stock price today
McKesson stock price monthly change
McKesson stock price quarterly change
McKesson stock price yearly change
McKesson key metrics
Market Cap | 72.45B |
Enterprise value | 77.90B |
P/E | 29.26 |
EV/Sales | 0.23 |
EV/EBITDA | 16.15 |
Price/Sales | 0.22 |
Price/Book | -24.59 |
PEG ratio | 3.67 |
EPS | 14.25 |
Revenue | 279.98B |
EBITDA | 4.36B |
Income | 1.93B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0.77% |
Oper. margin | 1.11% |
Gross margin | 3.88% |
EBIT margin | 1.11% |
EBITDA margin | 1.56% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMcKesson stock price history
McKesson stock forecast
McKesson financial statements
$614.75
Potential downside: -9.14%
Analysts Price target
Financials & Ratios estimates
Dec 2021 | 68.61B | -7M | -0.01% |
---|---|---|---|
Mar 2022 | 66.10B | 368M | 0.56% |
Mar 2023 | 68.91B | 787M | 1.14% |
Mar 2024 | 76.35B | 791M | 1.04% |
Payout ratio | 12.89% |
---|
2020 | 1.2% |
---|---|
2021 | 0.88% |
2022 | 0.59% |
2023 | 0.58% |
2024 | 0.44% |
Sep 2022 | 63081000000 | 64.33B | 101.98% |
---|---|---|---|
Dec 2022 | 62690000000 | 64.77B | 103.33% |
Mar 2023 | 62320000000 | 63.81B | 102.39% |
Mar 2024 | 67443000000 | 69.04B | 102.37% |
Dec 2021 | 1.37B | -115M | -438M |
---|---|---|---|
Mar 2022 | 2.88B | 183M | -1.98B |
Mar 2023 | 3.32B | -244M | -1.19B |
Mar 2024 | 4.14B | -577M | -968M |
McKesson alternative data
Aug 2023 | 45,000 |
---|---|
Sep 2023 | 45,000 |
Oct 2023 | 45,000 |
Nov 2023 | 45,000 |
Dec 2023 | 45,000 |
Jan 2024 | 45,000 |
Feb 2024 | 45,000 |
Mar 2024 | 45,000 |
Apr 2024 | 45,000 |
May 2024 | 45,000 |
Jun 2024 | 45,000 |
Jul 2024 | 45,000 |
McKesson other data
Period | Buy | Sel |
---|---|---|
Jan 2024 | 0 | 3908 |
Feb 2024 | 0 | 186 |
Mar 2024 | 0 | 3663 |
May 2024 | 0 | 23949 |
Jun 2024 | 0 | 4836 |
Jul 2024 | 0 | 3753 |
Aug 2024 | 0 | 3753 |
Sep 2024 | 0 | 3753 |
Dec 2024 | 0 | 579 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | SMITH LEANN B officer: EVP & Chief HR Officer | Common Stock | 579 | $602.81 | $349,027 | ||
Sale | TYLER BRIAN S. director, officer: Chief Execut.. | Common Stock | 3,753 | $561.1 | $2,105,808 | ||
Sale | TYLER BRIAN S. director, officer: Chief Execut.. | Common Stock | 3,753 | $626.03 | $2,349,491 | ||
Sale | TYLER BRIAN S. director, officer: Chief Execut.. | Common Stock | 3,753 | $580.92 | $2,180,193 | ||
Sale | SMITH LEANN B officer: EVP & Chief HR Officer | Common Stock | 600 | $585.53 | $351,318 | ||
Sale | MARTINEZ MARIA director | Common Stock | 483 | $585.88 | $282,979 | ||
Sale | TYLER BRIAN S. director, officer: Chief Execut.. | Common Stock | 3,753 | $574.41 | $2,155,761 | ||
Sale | RODGERS THOMAS L officer: EVP, Chief Strategy & .. | Common Stock | 5,232 | $560.99 | $2,935,100 | ||
Sale | VITALONE BRITT J. officer: EVP & CFO | Common Stock | 2,427 | $550 | $1,334,850 | ||
Sale | VITALONE BRITT J. officer: EVP & CFO | Common Stock | 2,427 | $550 | $1,334,850 |
Patent |
---|
Grant Filling date: 31 Mar 2016 Issue date: 13 Sep 2022 |
Grant Utility: Computing system and method for leveraging aggregated information to determine a unified purchasing solution Filling date: 31 Mar 2020 Issue date: 30 Aug 2022 |
Grant Utility: Computing system and method for automatically reversing an action indicated by an electronic message Filling date: 9 Nov 2020 Issue date: 16 Aug 2022 |
Grant Utility: Method and apparatus for parsing and differently processing different portions of a request Filling date: 31 Mar 2021 Issue date: 26 Jul 2022 |
Grant Utility: Systems and methods for determining and communicating a prescription benefit coverage denial to a prescriber Filling date: 27 Aug 2019 Issue date: 19 Jul 2022 |
Grant Filling date: 31 Mar 2017 Issue date: 12 Jul 2022 |
Grant Filling date: 29 Mar 2019 Issue date: 31 May 2022 |
Grant Utility: Computing device and method for message construction and processing based upon historical data Filling date: 5 Mar 2021 Issue date: 3 May 2022 |
Grant Utility: Method, apparatus, and computer program product for submission of medical eligibility and claim data Filling date: 23 Mar 2020 Issue date: 15 Feb 2022 |
Grant Filling date: 31 Mar 2020 Issue date: 30 Nov 2021 |
Quarter | Transcript |
---|---|
Q4 2024 7 May 2024 | Q4 2024 Earnings Call Transcript |
Q3 2024 7 Feb 2024 | Q3 2024 Earnings Call Transcript |
Q2 2024 1 Nov 2023 | Q2 2024 Earnings Call Transcript |
Q1 2024 2 Aug 2023 | Q1 2024 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Brian S. Tyler Ph.D. (1967) Chief Executive Officer & Director | $3,340,000 |
Ms. Lori A. Schechter J.D. (1962) Executive Vice President, Chief Legal Officer & Gen. Counsel | $2,300,000 |
Mr. Britt J. Vitalone (1969) Executive Vice President & Chief Financial Officer | $2,290,000 |
Mr. Thomas Rodgers M.B.A., MBA (1971) Executive Vice President and Chief Strategy & Bus. Devel. Officer | $2,230,000 |
Ms. Tracy L. Faber (1970) Executive Vice President & Chief HR Officer | $1,350,000 |
McKesson: Sustained Rally Backed By Strong Financials
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Biopharmaceutical Stocks: The Rally Has Just Begun
Walmart: Ozempic And Its Potential Impact On Grocery Sales
McKesson: Still Trading For A Huge Discount
McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation
McKesson Corporation Is A Stable Long-Term Addition
McKesson Corporation: Still Trading Below Intrinsic Value
Buffett's Berkshire: Why It's An Ideal Core Holding
-
What's the price of McKesson stock today?
One share of McKesson stock can currently be purchased for approximately $676.6.
-
When is McKesson's next earnings date?
Unfortunately, McKesson's (MCK) next earnings date is currently unknown.
-
Does McKesson pay dividends?
Yes, McKesson pays dividends and its trailing 12-month yield is 0.46% with 13% payout ratio. The last McKesson stock dividend of $0.47 was paid on 3 Jan 2022.
-
How much money does McKesson make?
McKesson has a market capitalization of 72.45B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11.65% to 308.95B US dollars.
-
What is McKesson's stock symbol?
McKesson Corporation is traded on the NYSE under the ticker symbol "MCK".
-
What is McKesson's primary industry?
Company operates in the Healthcare sector and Medical - Distribution industry.
-
How do i buy shares of McKesson?
Shares of McKesson can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are McKesson's key executives?
McKesson's management team includes the following people:
- Mr. Brian S. Tyler Ph.D. Chief Executive Officer & Director(age: 58, pay: $3,340,000)
- Ms. Lori A. Schechter J.D. Executive Vice President, Chief Legal Officer & Gen. Counsel(age: 63, pay: $2,300,000)
- Mr. Britt J. Vitalone Executive Vice President & Chief Financial Officer(age: 56, pay: $2,290,000)
- Mr. Thomas Rodgers M.B.A., MBA Executive Vice President and Chief Strategy & Bus. Devel. Officer(age: 54, pay: $2,230,000)
- Ms. Tracy L. Faber Executive Vice President & Chief HR Officer(age: 55, pay: $1,350,000)
-
How many employees does McKesson have?
As Jul 2024, McKesson employs 45,000 workers.
-
When McKesson went public?
McKesson Corporation is publicly traded company for more then 30 years since IPO on 10 Nov 1994.
-
What is McKesson's official website?
The official website for McKesson is mckesson.com.
-
Where are McKesson's headquarters?
McKesson is headquartered at 6555 State Highway 161, Irving, TX.
-
How can i contact McKesson?
McKesson's mailing address is 6555 State Highway 161, Irving, TX and company can be reached via phone at +972 4464800.
-
What is McKesson stock forecast & price target?
Based on 7 Wall Street analysts` predicted price targets for McKesson in the last 12 months, the avarage price target is $614.75. The average price target represents a -9.14% change from the last price of $676.6.
McKesson company profile:

McKesson Corporation
mckesson.comNYSE
45,000
Medical - Distribution
Healthcare
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Irving, TX 75039
CIK: 0000927653
ISIN: US58155Q1031
CUSIP: 58155Q103